Matthew Fuller, PhD is the Executive Director of Vector Platform Research at Ultragenyx. He is leading the Producer Cell Line and Vector Engineering teams, both of which perform program and platform research to continually optimize and invest in Ultragenyx’s gene therapy platforms and programs. Matthew has experience leading early-stage development programs and supporting multiple AAV programs for IND submission and clinical trials.

Matthew also serves on the FNIH Bespoke Gene Therapy Consortium (BGTC) AAV subcommittee, the American Society for Cell and Gene Therapy (ASGCT) Education committee, the Coalition to Cure CHD2 (CCC) Scientific Advisory Board, as Chief Scientific Advisor for the Cohen Syndrome Research Foundation (CSRF), and is serving a second term as an elected official on the Board of Health in Millis, Massachusetts. Matthew received a PhD in microbiology from the University of Missouri studying host-cell interactions of autonomous Parvoviruses with Dr. David Pintel, and a MSPH with a focus in Tropical Medicine from Tulane University.

Aaron Nagiel, MD, PhD is an Assistant Professor of Ophthalmology at Children’s Hospital Los Angeles, affiliated with the USC Roski Eye Institute/Keck School of Medicine in Los Angeles, California. As a surgeon specializing in retinal disorders of childhood and adolescence, he complements this clinical expertise with an active laboratory and translational research program. This includes the establishment of a nationally recognized retinal gene therapy program that has performed dozens of gene therapy surgeries, including for clinical trials.

Dr. Nagiel earned his bachelor’s degree from Harvard University summa cum laude, and then underwent combined MD and PhD training at Cornell University and The Rockefeller University in New York City. After an internship at Memorial Sloan-Kettering Cancer Center, Dr. Nagiel completed both ophthalmology residency and vitreoretinal fellowship at the Stein Eye Institute at UCLA.

Dr. Nagiel is a recipient of numerous grants and awards including the Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Fellowship Foundation Award, Knights Templar Eye Foundation Career Development Award, a National Eye Institute Clinical Scientist Training Grant (K08), and a Research to Prevent Blindness Career Development Award.